Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-21-082597
Date:2021-06-15
Issuer: CYCLACEL PHARMACEUTICALS, INC. (CYCC)
Original Submission Date:

Reporting Person:

SCHWARTZ BRIAN
C/O CYCLACEL PHARMACEUTICALS, INC.,
200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS, NJ 07922

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-06-15 A 2,374 a $0.00 3,561 direct
COMMON STOCK 2021-06-15 A 1,187 a $0.00 3,561 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 6.69 2021-06-15 deemed execution date A 4,748 (a) 2022-06-15 2031-06-15 common stock 4,748 $6.69 7,122 direct
STOCK OPTION (RIGHT TO BUY) 6.69 2021-06-15 deemed execution date A 2,374 (a) 2024-06-15 2031-06-15 common stock 2,374 $6.69 7,122 direct
Footnotes
IDfootnote
f1 the reporting person received an award of 2,374 restricted stock units on june 15, 2021, which shall vest in full on june 15, 2022.
f2 the reporting person received an award of 1,187 restricted stock units on june 15, 2021, which shall vest in three equal installments on june 15, 2022, june 15, 2023, and june 15, 2024.
f3 these options were granted to dr. schwartz for his services as a member of the board of directors of cyclacel pharmaceuticals, inc.
WhaleWisdom Logo

Elevate your investments